Overview
The actively managed fund uses a long-short equity strategy to exploit stock price anomalies in companies.
The investment in securities is made mainly in companies domiciled in the People`s Republic of China («PRC») listed within the PRC (onshore) or outside of the PRC (offshore).
The fund will engage in securities considered undervalued (long positions) and engage in short exposure in securities considered overvalued.
Securities are selected accordingly to a combination of fundamental, quantitative and qualitative research.
The Subfund may invest up to 100% of its assets in cash or money market-related securities for investment purposes.
The net equity position may therefore vary within a bandwidth of 0% to +125%.
This fund is not managed in reference to any benchmark.
Benefits
Access to alternative return streams in a daily liquid format.
Diversification and risk reduction potential when included in a traditional long-only portfolio with potential for enhanced returns.
Provides exposure to a strategy not typically available in daily liquid funds in a low cost, transparent format while providing diversification through access to a broad set of equities.
Risks
Features
| Product category |
Equity Asia |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 (Hong Kong) Ltd., Hong Kong
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS Fund Management (Switzerland) AG
|
| Day of inception |
February 25, 2020
|
| Currency of account |
USD
|
| Close of financial year |
September 30
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.04% p.a.
|
| Flat fee |
0.00% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.04% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark | |
| Cut-Off Time |
13:00h(CET)
|
| Securities no. |
50741508
|
| ISIN |
LU2072950194
|
| Bloomberg Ticker |
UCELSIX LX
|
Performance and Prices
Percentage growth
as of April 24, 2026| USD(%) | CHF(%) | EUR(%) | |
| YTD | -6.89 | -7.60 | -6.58 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 18.50 | 3.60 | 4.48 |
| 3Y | |||
| 5Y | -33.68 | -43.14 | -31.74 |
| ø p.a.5Y | -7.89 | -10.68 | -7.35 |
Current data
| Net asset value | 24.04.2026 | USD 89.33 |
| High - last 12 months | 17.09.2025 | USD 103.27 |
| Low - last 12 months | 28.04.2025 | USD 84.30 |
| Total product assets in mn | 24.04.2026 | USD 0.78 |
|
Date
|
2 years
|
5 years
|
|
| Sharpe Ratio | 31.03.2026 | 0.07 | -0.52 |
| Risk Free Rate | 31.03.2026 | 4.55% | 3.51% |
Structures
By detailed securities (in %, as of February 27, 2026)*
|
|
|
|
| 1 | Tencent Holdings Ltd | 9.83 |
| 2 | NetEase Inc | 9.64 |
| 3 | China Mobile Ltd | 8.28 |
| 4 | Alibaba Group Holding Ltd | 6.55 |
| 5 | Kweichow Moutai Co Ltd | 5.25 |
| 6 | Fuyao Glass Industry Group Co Ltd | 4.93 |
| 7 | China Merchants Bank Co Ltd | 4.25 |
| 8 | China Telecom Corp Ltd | 3.78 |
| 9 | Ping An Insurance Group Co of China Ltd | 3.76 |
| 10 | China Medical System Holdings Ltd | 3.69 |
| 11 | PDD Holdings Inc | 3.60 |
| 12 | Hong Kong Exchanges & Clearing Ltd | 2.65 |
| 13 | CITIC Securities Co Ltd | 2.44 |
| 14 | New Oriental Education & Technology Group Inc | 2.37 |
| 15 | China Resources Land Ltd | 2.26 |
| 16 | Lens Technology Co Ltd | 2.26 |
| 17 | Innovent Biologics Inc | 2.02 |
| 18 | Hangzhou Tigermed Consulting Co Ltd | 2.01 |
| 19 | Futu Holdings Ltd | 1.90 |
| 20 | China Resources Mixc Lifestyle Services Ltd | 1.81 |
| 21 | Value Partners Group Ltd | 1.74 |
| 22 | China Conch Venture Holdings Ltd | 1.58 |
| 23 | TAL Education Group | 1.56 |
| 24 | WuXi AppTec Co Ltd | 1.51 |
| 25 | Pop Mart International Group Ltd | 1.45 |
| 26 | ANTA Sports Products Ltd | 1.35 |
| 27 | CSPC Pharmaceutical Group Ltd | 1.30 |
| 28 | China Jinmao Holdings Group Ltd | 1.16 |
| 29 | KE Holdings Inc | 1.03 |
| 30 | China Overseas Land & Investment Ltd | 1.02 |
| 31 | Ping An Healthcare and Technology Co Ltd | 0.37 |
| 32 | Chinasoft International Ltd | 0.30 |
| 33 | SSY Group Ltd | 0.26 |
| 34 | ZhongAn Online P&C Insurance Co Ltd | 0.14 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
| Statutes / Management regulations |
|
|
|
Document type
|
Document Language
|
||
| Annual report |
|
|
|
| Semi-annual report |
|
|
|